Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2036|41|6|544-563
ISSN: 0269-2813
Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.6, 2015-03, pp. : 544-563
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract